VIVUS (Nasdaq: VVUS) shares are higher on the session following improving payment metrics for its obesity drug Qsymia.

According ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE